Skip to main content
Log in

Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Objectives

To assess, whether cardiac catheterization via radial access prevents contrast-induced nephropathy.

Background

Contrast-induced nephropathy (CIN) is a major clinical problem which accounts for more than 10% of acute kidney injury cases in hospitalized patients. Protective measures such as the infusion of isotonic saline solution or acetylcysteine have not consistently been proven to prevent acute kidney injury (AKI). However, there is growing evidence that radial access for coronary angiography and coronary intervention is associated with a lower incidence of AKI compared to femoral access.

Methods and results

In a retrospective monocentric analysis, 2937 patients that had undergone cardiac catheterization were examined. Up to 2013, coronary intervention was performed primarily via the femoral artery in our hospital; thereafter, interventions were primarily done via the radial artery. In the cohort under study, 1141 patients had received catheterization using the radial access while 1796 were examined via the femoral artery. No significant differences were found in the two groups regarding the amount of iodinated contrast medium applied [femoral group: 180 (120–260) ml; radial group: 180 (120–250) ml; P = 0.438]. A total of 400 (13.6%) patients developed acute kidney injury (AKI) after cardiac catheterization (85.3% AKI stage 1; 12.8% AKI stage 2; 2% AKI stage 3). AKI was significantly less frequent in patients that had received radial access compared to patients with femoral access (10.1 vs. 15.9%, P < 0.001). Multivariate regression analysis showed that patient age (1.03/year; 95% CI 1.02–1.04/year; P < 0.001), the amount of contrast media applied (OR 1.003/ml; 95% CI 1.002–1.004/ml; P < 0.001), acute coronary syndrome (OR 2.01, 95% CI 1.52–2.66; P < 0.001), CKD (OR 1.62, 95% CI 1.50–1.70; P < 0.001), pre-existing heart failure (OR 1.27, 95% CI 1.00–1.42 P = 0.007), previous myocardial infarction (OR 1.34, 95% CI 1.15–1.49; P = 0.001), diabetes (OR 1.25, 95% CI 1.04–1.41; P = 0.020) and serum creatinine before the procedure (1.45/mg/dl; 95% CI 1.24–1.69/mg/dl; P < 0.001) were important risk factors for the occurrence of AKI. Our analysis points to a significant risk reduction using radial access (OR 0.65; 95% CI 0.51–0.83; P < 0.001). Interestingly, this reduction in risk was also evident in patients with CKD (OR 0.59; 95% CI 0.41–0.87; P = 0.007). The superiority of radial access was particularly obvious in the subgroup of patients with acute coronary syndrome (13.1% AKI in the radial access group vs. 23.6% AKI in the femoral access group, OR 0.52; 95% CI 0.34–0.81; P = 0.003).

Conclusion

Our study shows that cardiac catheterization using radial access bears significantly lower risk of AKI than cardiac catheterization via femoral access. The advantage of radial access in acute coronary syndrome regarding morbidity and mortality could partly be explained by the here demonstrated reduced risk for AKI. Thus, radial access should be preferred in patients at risk for AKI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Feldkamp T, Kribben A (2008) Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention. Miner Med 99:177–196

    CAS  Google Scholar 

  2. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930–936. doi:10.1053/ajkd.2002.32766

    Article  PubMed  Google Scholar 

  3. Wickenbrock I, Perings C, Maagh P, Quack I, van Bracht M, Prull MW, Plehn G, Trappe HJ, Meissner A (2009) Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol 98:765–772. doi:10.1007/s00392-009-0058-5

    Article  PubMed  Google Scholar 

  4. Bell RM, Rear R, Cunningham J, Dawnay A, Yellon DM (2014) Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial. Clin Res Cardiol 103:203–209. doi:10.1007/s00392-013-0637-3

    Article  CAS  PubMed  Google Scholar 

  5. Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F (2012) Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation 125:3099–3107. doi:10.1161/CIRCULATIONAHA.111.085290

    Article  PubMed  Google Scholar 

  6. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602–1613

    Article  CAS  PubMed  Google Scholar 

  7. Kidney Disease (2012) Improving global outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138

    Article  Google Scholar 

  8. Fahling M, Seeliger E, Patzak A, Persson PB (2017) Understanding and preventing contrast-induced acute kidney injury. Nat Rev Nephrol 13:169–180. doi:10.1038/nrneph.2016.196

    Article  PubMed  Google Scholar 

  9. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J, Panel CINCW (2006) Risk prediction of contrast-induced nephropathy. Am J Cardiol 98:27K–36K. doi:10.1016/j.amjcard.2006.01.022

    Article  PubMed  Google Scholar 

  10. Ohlmeier C, Mikolajczyk R, Frick J, Prutz F, Haverkamp W, Garbe E (2015) Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons. Clin Res Cardiol 104:688–696. doi:10.1007/s00392-015-0841-4

    Article  PubMed  Google Scholar 

  11. Pohlen M, Bunzemeier H, Husemann W, Roeder N, Breithardt G, Reinecke H (2008) Risk predictors for adverse outcomes after percutaneous coronary interventions and their related costs. Clin Res Cardiol 97:441–448. doi:10.1007/s00392-008-0647-8

    Article  PubMed  Google Scholar 

  12. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399. doi:10.1016/j.jacc.2004.06.068

    PubMed  Google Scholar 

  13. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264

    Article  PubMed  Google Scholar 

  14. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329–336

    Article  CAS  PubMed  Google Scholar 

  15. Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, Ommen VV, Wildberger JE (2017) Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. The Lancet 389:1312–1322. doi:10.1016/S0140-6736(17)30057-0

    Article  Google Scholar 

  16. Kawashima S, Takano H, Iino Y, Takayama M, Takano T (2006) Prophylactic hemodialysis does not prevent contrast-induced nephropathy after cardiac catheterization in patients with chronic renal insufficiency. Circ J 70:553–558

    Article  PubMed  Google Scholar 

  17. Valgimigli M, Gagnor A, Calabro P, Frigoli E, Leonardi S, Zaro T, Rubartelli P, Briguori C, Ando G, Repetto A, Limbruno U, Cortese B, Sganzerla P, Lupi A, Galli M, Colangelo S, Ierna S, Ausiello A, Presbitero P, Sardella G, Varbella F, Esposito G, Santarelli A, Tresoldi S, Nazzaro M, Zingarelli A, de Cesare N, Rigattieri S, Tosi P, Palmieri C, Brugaletta S, Rao SV, Heg D, Rothenbuhler M, Vranckx P, Juni P, Investigators M (2015) Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. The Lancet 385:2465–2476. doi:10.1016/S0140-6736(15)60292-6

    Article  Google Scholar 

  18. Jolly SS, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, Budaj A, Niemela M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR, Group Rt (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. The Lancet 377:1409–1420 doi:10.1016/S0140-6736(11)60404-2

    Article  Google Scholar 

  19. Vuurmans T, Byrne J, Fretz E, Janssen C, Hilton JD, Klinke WP, Djurdjev O, Levin A (2010) Chronic kidney injury in patients after cardiac catheterisation or percutaneous coronary intervention: a comparison of radial and femoral approaches (from the British Columbia cardiac and renal registries). Heart 96:1538–1542. doi:10.1136/hrt.2009.192294

    Article  PubMed  Google Scholar 

  20. Ando G, Cortese B, Russo F, Rothenbuhler M, Frigoli E, Gargiulo G, Briguori C, Vranckx P, Leonardi S, Guiducci V, Belloni F, Ferrari F, de la Torre Hernandez JM, Curello S, Liistro F, Perkan A, De Servi S, Casu G, Dellavalle A, Fischetti D, Micari A, Loi B, Mangiacapra F, Russo N, Tarantino F, Saia F, Heg D, Windecker S, Juni P, Valgimigli M, Investigators M (2017) Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX. J Am Coll Cardiol. doi:10.1016/j.jacc.2017.02.070

    PubMed  Google Scholar 

  21. Vora AN, Stanislawski M, Grunwald GK, Plomondon ME, Rumsfeld JS, Maddox TM, Vidovich MI, Woody W, Nallamothu BK, Gurm HS, Rao SV (2017) Association between chronic kidney disease and rates of transfusion and progression to end-stage renal disease in patients undergoing transradial versus transfemoral cardiac catheterization-an analysis from the veterans affairs clinical assessment reporting and tracking (CART) program. J Am Heart Assoc. doi:10.1161/JAHA.116.004819

    Google Scholar 

  22. Freeman RV, O’Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M, Blue Cross-Blue Shield of Michigan Cardiovascular C (2002) Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90:1068–1073

    Article  PubMed  Google Scholar 

  23. Mueller C, Seidensticker P, Buettner HJ, Perruchoud AP, Staub D, Christ A, Buerkle G (2005) Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration. Swiss Med Wkly 135:286–290. doi:10.2005/19/smw-10938

    PubMed  Google Scholar 

  24. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44:1780–1785. doi:10.1016/j.jacc.2004.07.043

    Article  PubMed  Google Scholar 

  25. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95:13–19. doi:10.1016/j.amjcard.2004.08.056

    Article  PubMed  Google Scholar 

  26. Otaki Y, Watanabe T, Takahashi H, Funayama A, Kinoshita D, Yokoyama M, Takahashi T, Nishiyama S, Arimoto T, Shishido T, Miyamoto T, Konta T, Kubota I (2016) Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure. Clin Res Cardiol 105:162–171. doi:10.1007/s00392-015-0899-z

    Article  PubMed  Google Scholar 

  27. Shah R, Mattox A, Khan MR, Berzingi C, Rashid A (2017) Contrast use in relation to the arterial access site for percutaneous coronary intervention: a comprehensive meta-analysis of randomized trials. World J Cardiol 9:378–383. doi:10.4330/wjc.v9.i4.378

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nasri H, Mubarak M (2013) Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease. J Ren Inj Prev 2:107–108. doi:10.12861/jrip.2013.34

    PubMed  PubMed Central  Google Scholar 

  29. Scolari F, Ravani P (2010) Atheroembolic renal disease. The Lancet 375:1650–1660. doi:10.1016/S0140-6736(09)62073-0

    Article  Google Scholar 

  30. Hetherington SL, Adam Z, Morley R, de Belder MA, Hall JA, Muir DF, Sutton AG, Swanson N, Wright RA (2009) Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery. Heart 95:1612–1618. doi:10.1136/hrt.2009.170233

    Article  CAS  PubMed  Google Scholar 

  31. Schelp V, Freitag-Wolf S, Hinzmann D, Bramlage P, Frey N, Frank D (2015) Large-scale experience with an anchorless vascular closure device in a real-life clinical setting. Clin Res Cardiol 104:145–153. doi:10.1007/s00392-014-0766-3

    Article  PubMed  Google Scholar 

  32. Ohno Y, Maekawa Y, Miyata H, Inoue S, Ishikawa S, Sueyoshi K, Noma S, Kawamura A, Kohsaka S, Fukuda K (2013) Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. J Am Coll Cardiol 62:1260–1266. doi:10.1016/j.jacc.2013.03.086

    Article  PubMed  Google Scholar 

  33. Davenport MS, Khalatbari S, Cohan RH, Ellis JH (2013) Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level—and estimated glomerular filtration rate—based screening methods. Radiology 269:92–100. doi:10.1148/radiol.13122462

    Article  PubMed  PubMed Central  Google Scholar 

  34. McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, Misra S, Williamson EE, Kallmes DF (2013) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 267:106–118. doi:10.1148/radiol.12121823

    Article  PubMed  Google Scholar 

  35. Wilhelm-Leen E, Montez-Rath ME, Chertow G (2017) Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 28:653–659. doi:10.1681/ASN.2016010021

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark Luedde.

Ethics declarations

Conflict of interest

All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There are no commercial associations that might pose a conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 117 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feldkamp, T., Luedemann, M., Spehlmann, M.E. et al. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures. Clin Res Cardiol 107, 148–157 (2018). https://doi.org/10.1007/s00392-017-1166-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-017-1166-2

Keywords

Navigation